These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine. Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365 [TBL] [Abstract][Full Text] [Related]
23. Measurement of canine urinary thromboxanes by GC-MS and HPLC-RIA. Tagari P; Callaghan DH; Black C; Yerge JA Prostaglandins; 1994 Apr; 47(4):293-306. PubMed ID: 8041872 [TBL] [Abstract][Full Text] [Related]
24. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132 [TBL] [Abstract][Full Text] [Related]
25. Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. Rousson D; Guichardant M; Lagarde M; Viala JJ; Dechavanne M Br J Haematol; 1989 Jul; 72(3):402-6. PubMed ID: 2669929 [TBL] [Abstract][Full Text] [Related]
27. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542 [TBL] [Abstract][Full Text] [Related]
28. Increased renal TXA2 synthesis in diabetes mellitus: simultaneous determination of urinary TXB2 and 2,3-dinor-TXB2. Katayama S; Inaba M; Maruno Y; Omoto A; Kawazu S; Ishii J; Sawada M Prostaglandins Leukot Essent Fatty Acids; 1990 Jan; 39(1):47-51. PubMed ID: 2339136 [TBL] [Abstract][Full Text] [Related]
29. Prostacyclin production in myocardial infarction in the acute phase and during follow-up. Rasmanis G; Vesterqvist O; Gréen K; Edhag O; Henriksson P J Intern Med; 1991 Feb; 229(2):135-41. PubMed ID: 1997639 [TBL] [Abstract][Full Text] [Related]
30. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease. Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H Stroke; 1985; 16(2):241-4. PubMed ID: 3883580 [TBL] [Abstract][Full Text] [Related]
31. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity. Benigni A; Chiabrando C; Piccinelli A; Perico N; Gavinelli M; Furci L; Patino O; Abbate M; Bertani T; Remuzzi G Kidney Int; 1988 Aug; 34(2):164-74. PubMed ID: 3184595 [TBL] [Abstract][Full Text] [Related]
32. In vivo synthesis of thromboxane and prostacyclin in man in health and disease. Data from GC-MS measurements of major urinary metabolites. Gréen K; Vesterqvist O Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():309-24. PubMed ID: 2949557 [No Abstract] [Full Text] [Related]
33. Preparation of 2,3,4,5-tetranor-thromboxane B2, the major urinary catabolite of thromboxane B2 in the rat. Pace-Asciak CR; Edwards NS Methods Enzymol; 1982; 86():604-7. PubMed ID: 7132772 [No Abstract] [Full Text] [Related]
34. A chemiluminescent immunoassay for urinary thromboxane B2. Morello A; Chang S; Jacob A; Law SJ; Stastny M; Martin L; Pamidi A; Kotake A Prostaglandins; 1991 Jul; 42(1):55-70. PubMed ID: 1771240 [TBL] [Abstract][Full Text] [Related]
35. A critical evaluation of urinary immunoreactive thromboxane: feasibility of its determination as a potential vascular risk indicator. Lorenz RL; Uedelhoven WM; Fischer S; Ruetzel A; Weber PC Biochim Biophys Acta; 1989 Dec; 993(2-3):259-65. PubMed ID: 2597697 [TBL] [Abstract][Full Text] [Related]
36. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine. Hornych A; Krief C; Bariety J Prostaglandins Leukot Med; 1982 May; 8(5):467-80. PubMed ID: 6954551 [TBL] [Abstract][Full Text] [Related]
37. Metabolism of thromboxane B2 in man. Identification of the major urinary metabolite. Roberts LJ; Sweetman BJ; Payne NA; Oates JA J Biol Chem; 1977 Nov; 252(21):7415-7. PubMed ID: 914816 [TBL] [Abstract][Full Text] [Related]
38. Cigarette smoking: profiles of thromboxane- and prostacyclin-derived products in human urine. Barrow SE; Ward PS; Sleightholm MA; Ritter JM; Dollery CT Biochim Biophys Acta; 1989 Oct; 993(1):121-7. PubMed ID: 2679889 [TBL] [Abstract][Full Text] [Related]
39. Sex and age-related differences in the urinary excretion of TXB2 in normal human subjects: a possible pathophysiological role of TXA2 in the aged kidney. Chiba S; Abe K; Kudo K; Omata K; Yasujima M; Sato K; Seino M; Imai Y; Sato M; Yoshinaga K Prostaglandins Leukot Med; 1984 Dec; 16(3):347-58. PubMed ID: 6597456 [TBL] [Abstract][Full Text] [Related]